Fluoride exposure and bone status in patients with chronic intestinal failure who are receiving home parenteral nutrition

American Journal of Clinical Nutrition

Volumn 83, Issue 6, 2006, Pages 1429-1437

  Boulétreau, Paul H ^a   Bost, Muriel ^a,b   Fontanges, Elisabeth ^a   Lauverjat, Madeleine ^a   Gutknecht, Christel ^c   Ecochard, René ^c   Delmas, Pierre D ^a   Chambrier, Cécile ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Trace Elements Institute for UNESCO   (France)

^c LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

Author keywords

Bone mineral density; Chronic intestinal failure; Fluoride; Fluorosis; Home parenteral nutrition

Indexed keywords

FLUORIDE;

ABSORPTIOMETRY; ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE CLEARANCE; ENTEROPATHY; EXPOSURE; FEMALE; FLUOROSIS; HEALTH STATUS; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; OSTEOPENIA; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME; BLOOD; BONE; DRUG EFFECT; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; AGED; BONE AND BONES; BONE DENSITY; FEMALE; FLUORIDES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, HOME; RETROSPECTIVE STUDIES; SHORT BOWEL SYNDROME;

EID: 33745592822     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.6.1429     Document Type: Article

References (31)

1. Shike M, Sturtridge WC, Tam CS, et al. A possible role of vitamin D in the genesis of parenteral-nutrition-induced metabolic bone disease. Ann Intern Med 1981;95:560-8.
2. Shike M, Harrison JE, Sturtridge WC, et al. Metabolic bone disease in patients receiving long-term total parenteral nutrition. Ann Intern Med 1980;92:343-50.
3. Pironi L, Labate AM, Pertkiewicz M, et al. Prevalence of bone disease in patients on home parenteral nutrition. Clin Nutr 2002;21:289-96.
4. Cohen-Solal M, Baudoin C, Joly F, et al. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res 2003;18:1989-94.
5. Haderslev KV, Tjellesen L, Haderslev PH, Staun M. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2004;28:289-94.
6. Moukarzel A, Buchman AL, Vargas J, Baron HI, Ament ME. Is fluoride deficiency related to the bone disease of parenteral nutrition? Gastroenterology 1992;102:A568 (abstr).
7. Meunier PJ, Sebert JL, Reginster JY, et al. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVO Study. Osteoporos Int 1998;8:4-12.
8. Jacqmin-Gadda H, Commenges D, Dartigues JF. Fluorine concentration in drinking water and fractures in the elderly. JAMA 1995;273:775-6.
9. Noel C, Gosselin B, Dracon M, et al. [Risk of bone disease as a result of fluoride intake in chronic renal insufficiency. ] Nephrologie 1985;6:181-5 (in French).
10. Savas S, Cetin M, Akdogan M, Heybeli N. Endemic fluorosis in Turkish patients: relationship with knee osteoarthritis. Rheumatol Int 2001;21:30-5.
11. Li Y, Liang C, Slemenda CW, et al. Effect of long-term exposure to fluoride in drinking water on risks of bone fractures. J Bone Miner Res 2001;16:932-9.
12. Yates AA, Schlicker SA, Suitor CW. Dietary reference intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998;98:699-706.
13. World Health Organization Study Group. Assessement of osteoporotic fracture risk and its role in screening in post-menopausal osteoporosis. Geneva, Switzerland: World Health Organization Study Group, 1994.
14. Fuchs C, Dorn D, Fuchs CA, et al. Fluoride determination in plasma by ion selective electrodes: a simplified method for the clinical laboratory. Clin Chim Acta 1975;60:157-67.
15. Delmas PD, Dupuis J, Duboeuf F, Chapuy MC, Meunier PJ. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Miner Res 1990;5(suppl):S143-7.
16. Torra M, Rodamilans M, Corbella J. Serum and urine fluoride concentration: relationships to age, sex and renal function in a non-fluoridated population. Sci Total Environ 1998;220:81-5.
17. Buchman AL, Moukarzel A. Metabolic bone disease associated with total parenteral nutrition. Clin Nutr 2000;19:217-31.
18. Caverzasio J, Palmer G, Bonjour JP. Fluoride: mode of action. Bone 1998;22:585-9.
19. Rich C, Ensinck J. Effect of sodium fluoride on calcium metabolism of human beings. Nature 1961;191:184-5.
20. Ringe JD, Dorst A, Kipshoven C, Rovati LC, Setnikar I. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate. Osteoporos Int 1998;8:47-52.
21. Reginster JY, Meurmans L, Zegels B, et al. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial. Ann Intern Med 1998;129:1-8.
22. Riggs BL, Hodgson SF, O'Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802-9.
23. Meunier PJ, Femenias M, Duboeuf F, Chapuy MC, Delmas PD. [Increase in vertebral bone density in heavy drinkers of mineral water with a high fluoride content.] Presse Med 1989;18:1423-6 (in French).
24. Meunier PJ, Femenias M, Duboeuf F, Chapuy MC, Delmas PD. Increased vertebral bone density in heavy drinkers of mineral water rich in fluoride. Lancet 1989;1:152 (letter).
25. Krishnamachari KA, Krishnaswamy K. Genu valgum and osteoporosis in an area of endemic fluorosis. Lancet 1973;2:877-9.
26. Arlaud J, Lam-my S, Desch G, Pierre F. [Osteomalacia disclosing bone fluorosis caused by regular consumption of Vichy Saint-Yorre mineral water. ] Presse Med 1984;13:2393-4 (in French).
27. Boivin G, Chavassieux P, Chapuy MC, Baud CA, Meunier PJ. [Histomorphometric profile of bone fluorosis induced by prolonged ingestion of Vichy Saint-Yorre water. Comparison with bone fluorine levels.] Pathol Biol (Paris) 1986;34:33-9 (in French).
28. Chevrel G, Barbey E, Meunier PJ. [Pharmacokinetics of fluorine contained in the Royale Saint-Yorre mineral water.] Rev Rhum Ed Fr 1993;60:802-7 (in French).
29. Whitford GM, Pashley DH. Fluoride absorption: the influence of gastric acidity. Calcif Tissue Int 1984;36:302-7.
30. Murray. Fluorosis and nutrition in Morocco: dental studies in relation to environment. Br Dental J 1948;84:97-100.
31. Mitchell GA. The management of fluoride poisoning. In: Haddad LM, Winchester JF, eds. Clinical management of poisoning and drug overdose. Philadelphia, PA: WB Saunders Co, 1983:690-7.